AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Aveanna Healthcare Holdings (NASDAQ: AVAH)
›
Aveanna Healthcare Holdings (NASDAQ: AVAH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 3,500 employees.
The shares were at 10.70 USD on 19 November 2026, up 24.0% over 52 weeks. Its 52-week range is 5.930 USD to 14.71 USD: the price is 27.3% below the high and 80.4% above the low.
At a market capitalisation of 2.34B USD, it trades at 7.6 times trailing earnings and 11.7 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 23.7, a discount of 68% for AVAH.
Aveanna Healthcare Holdings reports return on equity of 115.3%, an operating margin of 12.4% and revenue up 11.8% year over year.
Its debt exceeds its cash by 1.34B USD, a debt-to-equity ratio of 7.76. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 15.20 USD is 42.1% above the current price. The next earnings report is expected on 11 March 2027.